Blog

November 24, 2015May 20, 2026

Revelling in its Dark Soul; Kaos Unveils the Black Collection

Kaos escapes from traditional frame designs and creates a collection that will amaze and stun. The black collection is designed to take you from day to night, nerdy chick to business conservative. Model KK367 has an acetate front offered in either a classic black or a lively two-tone colour combination, featuring temples with a stitched effect. KK366 is a bright and edgy frame with a two-tone acetate front with metal temples and highly coloured details on them.

Distributed by Centennial Optical: www.centennialoptical.com

November 23, 2015April 24, 2018

Alcon Introduces Personalized LASIK Procedure Contoura Vision

Alcon introduced Contoura Vision, an advancement in its WaveLight refractive portfolio during the annual meeting of the American Academy of Ophthalmology (AAO) in Las Vegas, November 14-17, 2015.

Contoura Vision is a topography-guided LASIK treatment designed to provide surgeons the ability to perform more personalized laser procedures for patients with nearsightedness, or nearsightedness with astigmatism, based on the unique corneal topography of each eye.

“We are pleased to provide surgeons with a technology that has been shown to deliver visual acuity better than glasses or contact lenses for nearly one-third of patient eyes in a clinical trial setting,” said Franck Leveiller, Head of Research & Development for Alcon’s Surgical Franchise. “Backed by FDA approval and very positive clinical trial outcomes, surgeons can now offer a topography-guided treatment option for refractive surgery patients in the US.”

Further information: https://www.novartis.com/news/media-releases/alcon-introduces-contoura-vision-first-personalized-lasik-procedure-american

November 23, 2015May 19, 2026

Allergan and Pfizer: Botox and Viagra Makers Merge

Biopharma giants Pfizer Inc. and Allergan plc announced unanimous board approval for the merger of the two companies, in a transaction value of $160 billion US. Under the agreement, Allergan shares are valued at a 30% premium as of the October 28 share price.

The combined company will operate under the Pfizer umbrella. The announcement touts the addition of growing revenue streams from Allergan’s portfolio, including Aesthetics and Dermatology, Eye Care and other therapeutic categories.

Read the full press release:

http://www.premierbiopharmaleader.com/en/media/press-releases/pfizer-and-allergan-to-combine/

November 20, 2015May 20, 2026

Maddox, Everett, Davis, Ellis and Bruno. Bring on the Men! Frames that is

Stunning shapes, rich in colour for a bolder look, and made from superior Mazzucchelli Italian acetates all finished by hand. Plan B Eyewear releases five new models for the Staag collection. Whether it is an oversized square design or a classic round shape with a modern twist, these frames are a must have for those looking for more punch in their eyewear collection.

Distributed by Plan B Eyewear; www.planbeyewear.com

November 20, 2015April 24, 2018

Medicated Eye Drops Slow Children’s Myopia Progression

Results from a five year clinical trial in Singapore, presented at the AAO annual meeting, show that low-dose atropine slowed the progression of myopia in school-age children.

The study began in 2006 and involved 400 children aged 6 to 12. The children were divided into 3 groups and randomly assigned either a 0.5, 0.1 or 0.01 percent dose of atropine, taken nightly, for two years.

The group receiving the 0.01% dose performed the best, showing 50% slower myopia progression compared to children not receiving atropine. At 0.01% the dose appeared safe, with minimal levels of pupil dilation and light sensitivity.

“For a long time we’ve known that atropine drops can help keep myopia from getting worse to some degree,” said Dr. Donald T. Tan, FRCS, FRCOphth, lead investigator and professor of ophthalmology at the Singapore Eye Research Institute and the National Singapore Eye Centre. “We now have data showing that it is not only effective, but also safe. Combined with other interventions, this treatment could become a great ally in preventing myopia from causing serious visual impairment in children worldwide.”

Further information: http://www.aao.org/newsroom/news-releases/detail/nearsightedness-progression-in-children-slowed-dow